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The parenchymal lung diseases caused by metal inhalation include interstitial ﬁbrosis, giant cell inter-
stitial pneumonitis, chemical pneumonitis, and granulomatous disease, among others. We reported two
cases of granulomatous lung disease with occupational exposure to metal dusts other than beryllium.
They had worked in the battery manufacturing industry for 7 years and in an aluminum-processing
factory for 6 years, respectively. Chest high-resolution computed tomography showed diffuse micro-
nodules, and histology of video-assisted lung biopsy specimens revealed granulomatous lesions in the
pulmonary interstitium. Results of microscopic examination of the tissue with special stains for myco-
bacteria and fungi were negative. Analysis by an electron probe microanalyzer with a wavelength-
dispersive spectrometer (EPMA-WDS) conﬁrmed the presence of silicon, iron, aluminum, and titanium
in the granulomas. In particular, aluminum was distributed in a relatively high concentration in the
granulomatous lesions. Although chronic beryllium disease is well known as an occupational granulo-
matous lung disease, much less is known about the other metals that cause granulomatous reactions in
humans. Our report pointed out manifestations similar to beryllium disease after other metal dust ex-
posures, in particular aluminum exposure. To our knowledge, this is the ﬁrst report showing two-
dimensional images of elemental mapping in granulomatous lesions associated with metal inhalation
using EPMA-WDS.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Various metal dusts and fumes can induce a wide range of lung
pathology, including not only parenchymal diseases but airwayer; WDS, wavelength disper-
e; SP-D, surfactant protein D;
ty; DLco, carbon monoxide
nchoalveolar lavage.
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Ltd. This is an open access article udisorders and cancer as well [1]. The parenchymal lung diseases
caused by metal inhalation include interstitial ﬁbrosis, giant cell
interstitial pneumonitis, chemical pneumonitis, and granuloma-
tous disease, among others [1]. Most of the disorders arise from
occupational exposures. A granulomatous disease caused by
beryllium, known as chronic beryllium disease since its description
by Hardy and Tabershaw [2], is a representative occupational
granulomatous lung disease. Similar manifestations are occasion-
ally reported from other metal dust exposures, such as to
aluminum, zirconium, titanium, earth metals, and talc, the latter of
which contains various amounts of aluminum and silica [3e11].
However, reports have been limited that describe the clinical,
radiographic, and pathological ﬁndings of conditions other than thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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information on mineralogical analyses of metal dusts.
An electron probe microanalyzer (EPMA) is an analytical tool
used to non-destructively determine the chemical composition of
small volumes of solid materials [12]. It irradiates specimens with a
ﬁnely focused electron beam to obtain information about the
elemental composition. Furthermore, EPMA with a wavelength-
dispersive spectrometer (WDS) has higher sensitivity [13]. EPMA-
WDS enables analysis of human lung tissue for deposits of ele-
ments by both qualitative and semi-quantitative methods [12]. We
applied EPMA-WDS to biopsied lung tissue from patients present-
ing with granulomatous lung diseases with occupational exposure
to metals other than beryllium to analyze the distribution of
elements.2. Case reports
2.1. Case 1
A 33-year-old man with a 12 pack-year history of cigarette
smoking was referred to our hospital in 2006 because of exertional
dyspnea. He had worked in the battery manufacturing industry for
7 years where hewas exposed to cobalt, nickel, zinc, aluminum, and
titanium. Beryllium was not used. He had begun working in that
industry in 1998, and shortly thereafter developed skin eruptions
with itching. In 2003, he was assigned by the company to a work-
place dealing with cobalt hydroxide powder. There he developed an
intense cough that was relieved after he left that workplace. He
became aware of the onset of exertional dyspnea in 2004, and
abnormal shadows on chest X-ray were detected at a health ex-
amination the next year. He left the industry and underwent ex-
aminations at a local hospital without a deﬁnite diagnosis. His past
medical history included acute enteritis at the age of 30 years and
depression at the age of 32 years. The patient's family history was
unremarkable.
Physical examination revealed a well-developed, well-nour-
ishedman. On chest auscultation, ﬁne crackles were heard subtly in
both sides of the back and an abdominal examination revealed a
smooth, non-tender liver edge 1 cm below the right costal margin.Fig. 1. Chest radiologic ﬁndings in Case 1. (A) Chest X-ray showed faint nodular shadows in
ﬁne nodular opacities that were distributed mainly in the upper and middle lung zones wNo evidence of uveitis, cervical or supraclavicular lymphadenopa-
thy, arthralgia, skin eruptions, or muscle weakness was found.
Laboratory investigations showed the following values: WBC
count 5900/mm3 with 2.5% eosinophils, Hb 15.8 g/L, C-reactive
protein 0.7 mg/dL, aspartate aminotransferase 74 U/L, alanine
aminotransferase 101 U/L, lactate dehydrogenase 254 IU/L, Y-glu-
tamyl transferase 417 U/L, creatinine 0.86 mg/dL, angiotensin
converting enzyme (ACE) 24.0 U/L (normal range 6e21 U/L), serum
KL-6 520 U/mL (normal range<500 U/mL), and surfactant protein D
(SP-D) 30.5 ng/mL (normal range <110 ng/mL). Results of immu-
nological tests were negative for autoimmune antibodies. Puriﬁed
protein derivative (PPD) skin testing was positive at indurations of
15 mm  15 mm. Arterial blood gas analysis while breathing room
air revealed hypoxemia (PaO2 60.2 Torr), with PaCO2 38.3 Torr and
pH 7.432. Although vital capacity (VC) was within normal range at
3.69 L (89.1%), both total lung capacity and carbon monoxide
diffusing capacity (DLco) were reduced to 4.33 L (69.4%) and
12.09 mL/min/Torr (40.8%), respectively.
Chest X-ray showed faint inﬁltrative shadows in the bilateral
outside lung ﬁelds (Fig. 1A). Chest high-resolution CT (HRCT)
revealed micronodules, most prominent in the upper and middle
lung zones with mediastinal lymph node enlargement (Fig. 1B).
Bronchoalveolar lavage (BAL) ﬂuids obtained previously at another
hospital had 8.4  105 cells per mL and 3.6% neutrophils, 0.8% eo-
sinophils, and 21.4% lymphocytes. The ratio of CD4 to CD8 T lym-
phocytes was 0.38.
A video-assisted lung biopsy was performed and histological
ﬁndings of tissue obtained from the left S1þ2 region are shown in
Fig. 2. Numerous epithelioid cell granulomas predominantly in the
pulmonary interstitium and hyalinous elastolytic ﬁbrosis predom-
inantly in the bronchiolovascular sheathwere observed. Epithelioid
cell granulomas were also observed in visceral pleura (not shown).
No giant cell interstitial pneumonia pattern was found. Results of
microscopic examination of the tissue with special stains for
mycobacteria and fungi were negative.
Because he had an occupational exposure to several kinds of
metals, examination of tissue sections with an EPMA-WDS was
performed according to procedures previously described [12,14].
Brieﬂy, with this procedure lung tissues are inﬂated, ﬁxed withthe bilateral lung ﬁelds. (B) Chest high-resolution computed tomography shows diffuse
ith mediastinal lymph node enlargement.
Fig. 2. Histological ﬁndings from surgical lung biopsy specimen from the left S1þ2
region in Case 1 (A,B). Epithelioid cell granuloma (arrow) in the pulmonary inter-
stitium and hyalinous elastolytic ﬁbrosis predominantly in the bronchiolovascular
sheath (hematoxylin and eosin stain, 20  and 40 ).
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ﬂoated on water drops on carbon blocks. Parafﬁn is thoroughly
removed by xylene, and the sample is coated with carbon evapo-
ration ﬁlms. Serial thin sections of the sample are attached to an
ultrapure carbon plate, then are dewaxed and processed for EPMA
(EPMA 8705; Shimadzu Ltd., Kyoto, Japan)-WDS analysis and
pathological examinations. EPMA images of a lung specimen are
shown in Fig. 3, and results by quantitative analysis are shown in
Table 1. Variousmetals mainly composed of silicon, iron, aluminum,
and titanium were detected in a hyalinized granulomatous lesion
(Table 1 Site 1). In particular, aluminum was widely distributed in
the granulomatous lesion (Fig. 3B). Various elements including
cobalt were also detected in the subpleural ﬁbrotic lesion with
black particle deposition (Table 1 Site 2). Tungsten was not
detected.
As the patient had a mental disorder, after removal from the
exposure he was followed up without corticosteroid therapy. Pul-
monary function tests obtained 4 years after he left his job (in 2009)
showed that VC and DLco were 3.58 L (76.6%) and 18.94 mL/min/
Torr (63.6%), respectively. Final laboratory investigations obtained
in 2010 showed the following values: ACE 28.5 U/L, serum KL-6
980 U/mL, and SP-D 33.0 ng/mL. Chest HRCT ﬁndings were not
changed. No extrathoracic involvement that would indicate suspi-
cion of sarcoidosis appeared.
2.2. Case 2
A 46-year-old man with no history of smoking was referred to
our hospital in 2008 because of abnormal opacities on chest ra-
diographs that were obtained at a local clinic where he had been
treated for bronchial asthma. He had worked in an aluminum-
processing factory for the past 6 years, from 1996 through 2001,
where he had been exposed to aluminum dust. Beryllium was not
used. He had not worn a protective mask. He had no signs of cough,
dyspnea, fever, skin involvement, or arthritis. His past medical
history included tuberculosis in childhood, gallstones at 21 years of
age, and bronchial asthma at 43 years of age. His medications
included theophylline, montelukast, olopatadine, beclometasone
dipropionate, and fenoterol hydrobromide. With regard to family
history, his mother had had tuberculosis.
Physical examination revealed a well-developed, well-nour-
ished man. Chest auscultation revealed no abnormal ﬁndings, and
there was no evidence of uveitis, cervical or supraclavicular
lymphadenopathy, arthralgia, skin eruption, or muscle weakness.
Laboratory investigations showed the following values: WBC
count 6280/mm3 with 0.6% eosinophils, Hb 16.8 g/L, C-reactive
protein 0.1 mg/dL, aspartate aminotransferase 17 U/L, alanine
aminotransferase 17 U/L, lactate dehydrogenase 195 IU/L, Y-glu-
tamyl transferase 21 U/L, creatinine 0.60 mg/dL, ACE 15.3 U/L,
serum KL-6 291 U/mL, and SP-D 25.0 ng/mL. QuantiFERON TB-2G
testing (Cellestis, Carnegie, Australia) was positive with culture
ﬁltrate protein-10 of 5.14 IU/mL, and the 6-kDa early secretory
antigenic target of Mycobacterium tuberculosis was 0.20 IU/mL
(normal range <0.35 IU/mL). PPD skin testing was positive for in-
durations of 27 mm  24 mm. Arterial blood gas analysis while
breathing room air did not reveal hypoxemia (PaO2 90.3 Torr), with
PaCO2 39.7 Torr and pH 7.433. Pulmonary function tests showed the
following values: VC 3.05 L (83.7%) and forced expiratory volume in
1 s 2.53 L (78.6%). Diffuse nodular shadows were found on chest X-
ray (Fig. 4A), and chest HRCT showed diffuse nodular opacities with
interlobular septal thickening (Fig. 4B). In BAL ﬂuids there were
3.1  105 cells per mL, with 1.0% neutrophils, 18.5% lymphocytes,
and 80.5%macrophages. The ratio of CD4 to CD8 T lymphocytes was
0.94. BAL ﬂuid cultures and acid-fast bacillus PCR were free of
pathogens. Histology performed on transbronchial biopsies did notreveal granuloma and no deﬁnite diagnosis could be made. Anti-
tuberculosis drug therapy using rifampicin, isoniazid, ethambutol,
and pyrazinamide for 3 months did not improve the chest HRCT
ﬁndings. Then a video-assisted lung biopsy was performed. Results
of histology of tissue obtained from the right S3 region are shown in
Fig 5. Granulomatous lesions mainly composed of multinucleated
giant cells were observed predominantly in the pulmonary inter-
stitium. Results of microscopic examination of the tissue with
special stains for mycobacteria and fungi were negative. Hemosi-
derosis and anthracosis with pneumoconiotic materials were also
observed (not shown). Elemental analysis was performed for the
granuloma (Fig. 6A) and the centrilobular ﬁbrosing lesion (Fig. 6C).
Silicon, aluminum, iron, and titaniumwere detected in both lesions
(Table 1 Site 3 and 4). Especially wide distribution of aluminumwas
observed in the granuloma (Fig. 6B).
The patient was followed up without special medication though
2014 when his chest HRCT ﬁndings showed no changes and he was
without respiratory symptoms.
Fig. 3. Electron probe microanalyzer images of a lung specimen from Case 1. (A) Gray scale image (left) of the granulomatous lesion obtained from the circled region in the lung
specimen stained with hematoxylin and eosin (right). A square, 10  10 mm, indicated by the yellow arrowhead numbered 1, was quantitatively analyzed, with results shown in
Table 1 Site 1. (B) Qualitative color image of aluminum distribution is superimposed on the lung tissue image with amino nitrogen colored green. Because the distribution of amino
nitrogen corresponds to the pathologic image, detected elements colored red are easily localized in the lung specimen. (C) Gray scale image (left) of the subpleural lesion with black
particle deposition obtained from the circled region in the lung specimen stained with hematoxylin and eosin (right). A square, 10  10 mm, indicated by the yellow arrowhead
numbered 2, was quantitatively analyzed, with results shown in Table 1 Site 2.
Table 1
Electron probe microanalyzer results by quantitative analysis.
Case 1 Case 2
Site 1 Site 2 Site 3 Site 4
O 54.954% O 37.343% Si 36.373% Fe 68.914%
Si 26.768% Si 20.404% O 29.720% O 14.449%
Al 13.790% Fe 12.546% Fe 15.203% Si 5.957%
K 2.132% Al 11.264% Al 8.927% P 2.469%
Fe 0.558% Ti 7.497% K 2.778% Al 2.381%
S 0.328% K 6.019% Ca 1.688% Ca 2.307%
Ca 0.304% Mg 1.696% Ti 1.567% S 0.970%
Ba 0.277% Ca 0.840% Mg 1.184% Zn 0.823%
P 0.263% P 0.638% Na 1.071% Ti 0.697%
Ti 0.248% Zn 0.477% P 0.780% K 0.473%
Mg 0.246% S 0.376% S 0.709% Mg 0.614%
Na 0.131% Ni 0.253% Na 0.196%
Co 0.244%
Mn 0.203%
Na 0.120%
Cl 0.080%
In Case 1 various metals, mainly silicon, iron, aluminum, and titanium, were
detected in hyalinized granulomatous lesion (Site 1) and those including cobalt
were detected in the subpleural ﬁbrotic lesion (Site 2). In Case 2 various metals
mainly composed of silicon, aluminum, iron, and titanium were detected in the
granuloma (Site 3) and centrilobular ﬁbrosing lesion (Site 4).
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We reported here two cases of granulomatous lung disease with
occupational exposure to metals. The ﬁrst case had worked in the
battery manufacturing industry for 7 years and the second case had
worked in an aluminum-processing factory for 6 years. Both men
were exposed to metals other than beryllium, and analysis by
EPMA-WDS conﬁrmed the presence of silicon, iron, aluminum, and
titanium in the granulomas. Although chronic beryllium disease is
well known as an occupational granulomatous lung disease, much
less is known about the other metals that cause granulomatous
reactions in humans. Silicon, aluminum, and iron are commonly
found in healthy human lung, however, wide distribution of
aluminum was observed in the granulomatous lesions in both
cases. Our report pointed out manifestations similar to beryllium
disease after other metal dust exposures, in particular aluminum
exposure.
A number of pulmonary effects have been attributed to
aluminum exposure including bronchial asthma, chronic bron-
chitis, pulmonary ﬁbrosis, granulomatous lung disease, acute tra-
cheobronchitis, pneumonitis, alveolar proteinosis, and pulmonary
edema [1,11]. Pneumoconiosis caused by the presence of dust
containing aluminum in lung tissue is known as pulmonary alu-
minosis. It is caused by the exposure to aluminum and its com-
pounds under diverse occupational circumstances and factors [15].
Of these granulomatous lung diseases, those induced by aluminum
Fig. 4. Chest radiologic ﬁndings in Case 2. (A) Chest X-ray showed diffuse nodular shadows (B). Chest high-resolution computed tomography shows diffuse nodular opacities with
interlobular septal thickening.
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granulomatosis associated with aluminum-containing welding
fumes. De Vuyst et al. [5] reported a case of sarcoid-like gran-
ulomatosis in a chemist who worked with aluminum powders.
Lung granulomatosis attributed to occupational exposure to
beryllium and aluminum was also reported in a dental laboratory
technician [16]. Later Cai et al. [6] reported a case of sarcoid-like
granulomatosis induced by aluminum dust in a metal reclamationFig. 5. Histological ﬁndings in surgical lung biopsy from the right S3 region in Case 2. (A,B
pulmonary muscular artery (hematoxylin and eosin stain, 10  and 40 ); (C) argyrophilicfactory worker. Based upon their occupational histories, in our
cases after exclusion of infectious agents and the performance of
combined histological and mineralogical studies, aluminum dust
could account for the development of pulmonary granulomas.
The exact pathogenesis of aluminum-induced diseases of lung
parenchyma is unknown [15]. Kraus et al. [17] conducted a cross-
sectional study to detect early stages of aluminosis using HRCT in
two plants that produced aluminum powder in Germany. They) granulomatous lesion mainly composed of multinucleated giant cells in adventitia of
ﬁber formation around multinucleated giant cells (silver stain, 40 ).
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in the upper lobes in 15 of 62 highly exposed workers. Their re-
ported CT ﬁndings resembled those in our cases. Although no bi-
opsy results were available in their study, some of their cases might
have had granulomatous lung disease with occupational exposure
to aluminum, as with our cases. That study also showed that not all
highly exposed workers with plasma and urinary concentrations of
aluminum were found to have parenchymal changes. Therefore,
individual susceptibility is suggested to play an important role in
the development of aluminosis [17].
In addition to exposure to aluminum, Case 1 was exposed to
cobalt, nickel, zinc, and titanium. These metals were identiﬁed in
the granulomatous lesion by elemental analysis using EPMA-WDS,
although only very small amounts of titanium were found. Redline
et al. [18] reported a case of granulomatous disease associated with
pulmonary deposition of titanium. The patient had worked as a
furnace feeder for an aluminum smelting company where he was
exposed to various metallic fumes and dusts released in the pro-
duction of aluminum and zinc alloys. Scanning electronmicroscopy
with energy dispersive X-ray analysis of a transbronchial biopsy
specimen from the patient's lung showed that the pulmonary
granulomas contained large numbers of metallic particulates of
aluminum with titanium and other metals. They suggested an
etiological role between the inhalation of titanium and a granulo-
matous disease process based on cellular immunological studies
that showed abnormal lymphocyte transformation tests to tita-
nium chloride and normal responses to aluminum, nickel, and
beryllium. We did not perform cellular immunological studies;
however, titanium might also have been associated with the
granulomatous lung disease in our Case 1.
Furthermore we must mention the association of cobalt in thisFig. 6. Electron probe microanalyzer images of a lung specimen from Case 2. A) Gray scale
specimen stained with hematoxylin and eosin (right). A square, 10  10 mm, indicated by t
Table 1 Site 3. (B) Qualitative colored image of aluminum distribution (colored red) is supe
image (left) of the ﬁbrosing lesion around the bronchiole obtained from the squared region i
indicated by the yellow arrowhead numbered 4, was quantitatively analyzed, with resultscase. Cobalt exposure alone has been rarely associated with
parenchymal lung disease. This led to the widespread belief that
simultaneous inhalation of other metals such as tungsten carbide is
essential for development of parenchymal disease [19]. Hard metal
is a synthetic compound that combines tungsten carbide with co-
balt as well as a number of other metals, and some hard metal
exposures have resulted in manifestations of granulomatous
pneumonitis [20,21]. Case 1 was exposed to cobalt but did not use
tungsten, so hard metal disease is not indicated. In fact, patholog-
ical ﬁndings in this case did not show the presence of bizarre,
cannibalistic, giant, multinucleated cells, a hallmark of hard metal
disease, classically seen in giant cell interstitial pneumonia [22].
However cobalt is never found in healthy subjects, so the element
might be pathogenetic to Case 1.
Interestingly, an elevation in serum ACE levels was observed in
Case 1, so the differential diagnosis in this case included sarcoidosis.
However, the following ﬁndings indicate negativity for sarcoidosis:
positive PPD skin test, BAL ﬂuid ﬁndings without elevation of the
ratio of CD4 to CD8 T lymphocytes, and no extrathoracic involve-
ment including uveitis in the follow-up period. Serum levels of ACE
are elevated in a variety of granulomatous disorders, including not
only sarcoidosis [23,24] but also silicosis [24,25], miliary tubercu-
losis [24], berylliosis [26], and leprosy [27]. Smolkova et al. [28]
reported a case of occupational pulmonary aluminosis presenting
with numerous dispersed micronodules and bilateral hilar
enlargement on chest images in which sarcoidosis was ﬁrst diag-
nosed without detailed knowledge of occupational history. The
clinical and pathological similarities between metal-induced dis-
ease and sarcoidosis should be recognized [11].
Various techniques can be employed in the evaluation of min-
eral dusts within lung tissues. We applied EPMA-WDS to biopsiedimage (left) of the granulomatous lesion obtained from the squared region in the lung
he yellow arrowhead numbered 3, was quantitatively analyzed, with results shown in
rimposed on the lung tissue image with amino nitrogen colored green. (C) Gray scale
n the lung specimen stained with hematoxylin and eosin (right). A square, 10  10 mm,
shown in Table 1 Site 4.
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lung disease. This technique can produce elemental distribution
maps that can be subsequently compared to the pathology of a
serial tissue section [12]. Although most studies that have analyzed
organic samples by EPMA used an energy dispersive spectrometer,
WDS is almost 10 times more sensitive than energy dispersive
spectrometer for all elements (13). EPMA-WDS is useful to analyze
the distribution of elements in hard metal lung disease [29].
Therefore, the use of this technique provided an accurate identiﬁ-
cation of the deposits observed within the granulomatous lesions
and supported a causal association with the type of exposure re-
ported by the patient and his granulomatous lung disease. To our
knowledge, this is the ﬁrst report showing two-dimensional images
of elemental mapping in granulomatous lesions associated with
metal inhalation using this method.
In summary, metal dusts other than beryllium can induce
granulomatous lung diseases. EPMA-WDS is a promising technique
for mineralogical analysis of lung samples from patients with
occupational granulomatous lung diseases.
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